These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14619525)

  • 1. [Development of a novel gene therapy using survivin antisense expressing adenoviral vectors].
    Yamamoto T; Manome Y; Miyamoto A; Tanigawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1805-8. PubMed ID: 14619525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer gene therapy using a survivin mutant adenovirus.
    Mesri M; Wall NR; Li J; Kim RW; Altieri DC
    J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
    Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
    Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
    J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
    Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
    Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
    Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
    Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.
    Yamamoto T; Manome Y; Nakamura M; Tanigawa N
    Eur J Cancer; 2002 Nov; 38(17):2316-24. PubMed ID: 12441269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of antisense oligodeoxynucleotide targeting survivin gene for cisplatin resistant human lung adeno-carcinoma xenograft in nude mice].
    Zhang MC; Hu CP; Chen Q; Xia Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):717-22. PubMed ID: 17062938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.
    Coma S; Noe V; Lavarino C; Adán J; Rivas M; López-Matas M; Pagan R; Mitjans F; Vilaró S; Piulats J; Ciudad CJ
    Oligonucleotides; 2004; 14(2):100-13. PubMed ID: 15294074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
    Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT
    Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tumor-specific promoter activities in melanoma.
    Lu B; Makhija SK; Nettelbeck DM; Rivera AA; Wang M; Komarova S; Zhou F; Yamamoto M; Haisma HJ; Alvarez RD; Curiel DT; Zhu ZB
    Gene Ther; 2005 Feb; 12(4):330-8. PubMed ID: 15696177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
    Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT
    Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antisense oligonucleotide targeting survivin affects the proliferation and apoptosis of SMMC-7721 cells].
    Pan K; Liu X; Yang C; Wang Y; Wang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):625-9. PubMed ID: 16856403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advances on inhibitor of apoptosis, survivin].
    Yang J; Liu FX; Yan XC
    Ai Zheng; 2003 Jul; 22(7):771-4. PubMed ID: 12866973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
    Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
    Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.
    Uchida H; Tanaka T; Sasaki K; Kato K; Dehari H; Ito Y; Kobune M; Miyagishi M; Taira K; Tahara H; Hamada H
    Mol Ther; 2004 Jul; 10(1):162-71. PubMed ID: 15233951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice.
    Sun Y; Lin R; Dai J; Jin D; Wang SQ
    Oligonucleotides; 2006; 16(4):365-74. PubMed ID: 17155911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.